The primary objective of this study is to assess the efficacy of laquinimod as treatment in participants with HD after 52 weeks using the Unified Huntington\'s Disease Rating Scale Total Motor Score (UHDRS-TMS or TMS).
The primary objective of this study is to assess the efficacy of laquinimod as treatment in participants with HD after 52 weeks using the Unified Huntington\'s Disease Rating Scale Total Motor Score (UHDRS-TMS or TMS).
País»Canada,Germany,Italy,Netherlands,Portugal,Russian Federation,Spain,United Kingdom,United States
Diseño del estudio»Ensayo controlado aleatorizado (ECA)